Results

Total Results: over 10,000 records

Showing results for "cancer".
Users also searched for: colon cancer screening

  1. www.uspreventiveservicestaskforce.org/Home/GetFile/1/17045/pancreatic-cancer-screening-final-evidence-review/pdf
    August 01, 2019 - Other exocrine tumors include solid- pseudopapillary neoplasm (<1%), acinar cell carcinoma (<1%), pancreatoblastoma … Typically, resectable tumors include those where the tumor has not grown large enough to invade any … Mucinous Neoplasm. … The prevalence of pancreatic intraepithelial neoplasia in pancreata with uncommon types of primary neoplasmsNeoplasm in a Referral Center.
  2. hcup-us.ahrq.gov/toolssoftware/ccs/CCSCategoryNames_FullLabels.pdf
    October 07, 2016 - myeloma 41 Cancer; other and unspecified primary 42 Secondary malignancies 43 Malignant neoplasm without … Other secondary malignancy 2.13 Malignant neoplasm without specification of site [43] 2.14 Neoplasmsneoplasms 2.16.1 Benign neoplasm of uterus [46] 2.16.2 Other and unspecified benign neoplasm [47] 2.16.2.1 … Benign neoplasm of ovary 2.16.2.2 Benign neoplasm of colon 2.16.2.3 Benign neoplasm of the thyroid 2.16.2.4 … Benign neoplasm of cerebral meninges 2.16.2.5 Other and unspecified benign neoplasms 3 Endocrine; nutritional
  3. www.uspreventiveservicestaskforce.org/home/getfilebytoken/dKPBY-h5PbactdPHgVHbz_
    June 01, 2003 - Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms … The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers … Incidence of basal cell carcinoma and squamous cell carcinoma and number of tumors among subjects with … Cases of malignant neoplasms excluding nonmelanoma skin CA; lung CA; malignant CA mortality; cardiovascular … Any malignant neoplasm except non- melanoma skin CA, primary-lung CA.
  4. www.uspreventiveservicestaskforce.org/uspstf/recommendation/testicular-cancer-screening-1996
    January 01, 1996 - in asymptomatic persons is limited to a small number of case reports. 14 Tumor markers, including … urologists, radiographic studies, or invasive procedures (e.g., biopsy or inguinal exploration) before malignancy … Common errors occurring in the diagnosis of testicular neoplasms and the effect of these errors on prognosis … Testicular tumors: delay in diagnosis and influence on survival. … Serum markers in testicular germ-cell neoplasms.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
    April 20, 2015 - early-stage cancers, the death rate from kidney cancer has not changed significantly over the same … in the range of 0.55 to 0.65.[3, 16- 18] The best predictors of malignancy are male sex and tumor size … – who have the highest risk of having aggressive malignancies. … Given the increased incidence in early, low-stage tumors without improvement in cancer-related deaths … Frank, I., et al., Independent validation of the 2002 American Joint Committee on cancer primary tumor
  6. effectivehealthcare.ahrq.gov/products/head-neck-cancer-update/research-protocol
    February 04, 2014 - tumors otologic tumors cutaneous tumors of the head and neck (including melanoma) thyroid cancer … parathyroid cancer esophageal cancer trachea tumors All therapeutic strategies will be included … OR (("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [TIAB] OR tumours … "[Mesh] OR (("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [TIAB … "[Mesh] OR (("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [TIAB
  7. effectivehealthcare.ahrq.gov/products/cancer-drugs-utilization/research
    August 26, 2011 - Points #7: Utilization of anticancer biologic products among Medicare beneficiaries, by diagnostic cancermalignancies and/or head and neck cancer (an off-label use). … indicative of its use in malignant neoplasms of the genitourinary tract (e.g., bladder cancer). … to the National Comprehensive Cancer Network. … Such use is not uncommon in cancer patients who have failed more traditional treatments.
  8. effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_executive.pdf
    February 01, 2016 - Given the increased incidence in early, low-stage tumors without improvement in cancer-related deaths … Tumor Characteristics 9 Low Increasing RENAL nephrometry score is consistently associated with malignancy … Importantly, cancer-specific survival was associated with tumor size/stage, but not partial or radical … However, differences in cancer-specific survival among modalities is likely unrelated to age or tumor … Current composite models do not reliably predict malignancy; however, tumor size and male sex are most
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-cancer_research-protocol.pdf
    August 10, 2016 - ) and squamous cell carcinoma (SCC), are the most common malignancies in the U.S.1 BCC and SCC are collectively … Cancer Council Australia and Australian Cancer Network. 2008. 26. … or "Oropharyngeal Neoplasms"[Mesh] OR Pharynx OR Pharyngeal neoplasms OR "Pharyngeal Neoplasms"[Mesh … ] or "Lung Neoplasms"[Mesh] or "Urinary Bladder Neoplasms"[Mesh] or "Uterine Cervical Neoplasms"[Mesh … ] or "Esophageal Neoplasms"[Mesh] or "Laryngeal Neoplasms"[Mesh])) AND (((Surger* or surgic*) and
  10. effectivehealthcare.ahrq.gov/products/cancer-anemia-update/research-protocol
    June 16, 2010 - The prevalence of anemia varies according to the type of neoplasia. 7 Patients with hematological malignancies … versus hematological malignancies versus mixed (studies including both solid tumors and hematological … * OR tumor OR tumors OR tumour* OR neoplas* OR carcinom* #59 Search erythropoietin OR epoetin* OR … AND ("Neoplasms"[Mesh] OR "Carcinoma"[Mesh] OR malignan* OR cancer OR cancers OR cancerous OR oncolog … * OR myelodysplas* OR tumor OR tumors OR tumour* OR neoplas* OR carcinom*) AND ("adverse effects
  11. hcup-us.ahrq.gov/reports/factsandfigures/figures/2006/2006_4_3.jsp
    January 01, 2006 - 3.5 18,027 Thyroid disorders 2.7 18,032 Epilepsy, convulsions 3.6 18,074 Benign … endocrine, and metabolic disorders 3.6 31,256 Digestive congenital anomalies 5.9 31,655 Malignantneoplasm without specification of site 7.6 31,798 Other benign neoplasm 4.4 31,832 … conditions 7.4 33,152 Paralysis 7.6 33,230 Chronic renal failure 5.3 33,422 Neoplasms … of other urinary organs 6.2 38,019 Secondary malignancies 7.1 38,140 Osteoarthritis
  12. hcup-us.ahrq.gov/reports/factsandfigures/figures/2006/2006_5_3a.jsp
    January 01, 2006 - Cancer Cancer Conditions with the Greatest Change in Number of Discharges Between 1997 and … Cancer of cervix 27 -39% Cancer of breast 121 -32% Cancer of ovary 40 … -30% Cancer of bladder 43 -20% Cancer of prostate 99 -17% Cancer of head and … neck 43 -17% Cancer of bronchus, lung 200 -10% Cancer of brain and nervous system … 40 3% Leukemias 66 6% Cancer of pancreas 40 14% Neoplasms of unspecified
  13. www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening-1996
    January 01, 1996 - FOBT can also miss small adenomas and colorectal malignancies that bleed intermittently or not at all … Distribution of colorectal neoplasms. A left-to-right shift of polyps and cancer. … Screening for colon malignancy with colonoscopy. … Large colonoscopic neoplasms missed by endoscopy. … The incidence of benign and malignant neoplasms of the colon and rectum: a postmortem study.
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiotherapy-proton-beam_research.pdf
    May 01, 2012 - analysis included all Medicare ben- eficiaries with claims indicating a diagno- sis in the malignant or benignneoplasms range of the ICD-9 codes (140-239) and receipt of proton beam therapy (HCPCS 77520-77525 … cancers (Table 7). … Typically a prostate cancer case will have this daily charge 30 times, and ocular tumor 5 times. … fur- ther multiplied by the fact that with 6 to 8 weeks of therapy (compared to one week for ocular neoplasms
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-pancreas_research-protocol.pdf
    August 09, 2013 - Studies that report data by tumor (e.g., percentage of pancreatic adenocarcinoma tumors that were correctly … Diagnostic management of pancreatic cancer. Cancers. 2011 Mar;3(1):494-509. 5. … exp pancreas, exocrine/) and (neoplasm/ or adenocarcinoma/ or neoplasms/)) or pancreas tumor/ or Pancreatic … r$ or sarcoma$ or neoplasm$ or carcinoma$ or adenocarcinoma$)).mp. 4 neuroendocrine tumors/ and … and imaging and diagnosis 17 and 23 25 Staging Cancer staging/ or Neoplasm staging/ 26 ((mass
  16. www.uspreventiveservicestaskforce.org/uspstf/recommendation/pancreatic-cancer-screening-1996
    January 01, 1996 - diagnosis.[[1,1a] Of pancreatic adenocarcinomas, which account for more than 90% of all pancreatic neoplasms … Most persons with pancreatic malignancy have elevated levels of certain serologic markers such as CA19 … given a positive screening test to be 0.5% only one of the four cancers discovered could be curably … A clinical evaluation of various tumor markers for the diagnosis of pancreatic cancer. … Gastrointestinal Tumor Study Group.
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/pediatric-cancer-survivorship-protocol.pdf
    June 01, 2020 - kidney failure, liver disease, osteopenia and osteoporosis, neurocognitive deficits, and secondary malignancies … for CCS is critical to minimize and alleviate disparities due to the adverse sequelae of their prior malignancy … *” OR “oncolog*” OR “neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR “malignan … *” OR “oncolog*” OR “neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR “malignan … *” OR “oncolog*” OR “neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR “malignan
  18. www.uspreventiveservicestaskforce.org/home/getfilebytoken/NZcLsqV-5K7hyfot-qHQp9
    November 01, 2004 - We performed a separate search for 2 new bladder tumor markers, NMP22 (nuclear matrix protein 22) and … BTA (bladder tumor antigen). … We used tumor markers, sensitivity and specificity, and antigens, neoplasm as “exploded” MeSH terms and … Among 7 men with well-differentiated tumors, none progressed to muscle-invasive disease after 7 years … Since these cancers may or 2 Screening for Bladder Cancer: Brief Evidence Update 3 Screening for
  19. www.uspreventiveservicestaskforce.org/uspstf/recommendation/thyroid-cancer-screening-1996
    January 01, 1996 - , which comprises about 10% of all thyroid malignancies, is inherited in one fourth of cases as part … any thyroid disease (compared to examination at surgery for hyperparathyroidism), and 4 of 6 thyroid tumors … given detection of any nodular disease was only 3%, but the likelihood of malignancy among patients … was detected by screening (98%) when compared with those presenting with symptoms (90%). 18 Cancers … Thyroid neoplasia following low-dose radiation in childhood.
  20. www.uspreventiveservicestaskforce.org/uspstf/document/brief-evidence-summary/bladder-cancer-screening-2004
    June 07, 2004 - We combined "bladder neoplasms" separately with "mass screening," which yielded 28 citations, and with … We performed a separate search for 2 new bladder tumor markers, NMP22 (nuclear matrix protein 22) and … BTA (bladder tumor antigen). … We used "tumor markers," "sensitivity and specificity," and "antigens, neoplasm" as "exploded" MeSH® … Among 7 men with well-differentiated tumors, none progressed to muscle-invasive disease after 7 years